University of California, Los Angeles
Los Angeles, California, 90095, United States
NCT Number: NCT05026333
The goal of this pilot part of the study (Step 1) is to identify the optimal population of high and low anxiety and stress individuals who will differentially respond to a laboratory stress task as measured by changes in subjective stress response (affect), cognition, attention, and biological measures (autonomic and metabolite responses).
Based on experience with different study populations, the investigator's believe that a healthy, homogenous population (Caucasian, women, premenopausal) with higher levels of state anxiety and perceived stress, and with greater responsiveness to laboratory stress tasks (which can also be used in the probiotic intervention study in Step 2) will provide the highest likelihood of identifying the underlying central mechanisms of stress responsiveness in Step 1 and then for the probiotic intervention in Step 2.
For this pilot study, the investigator's will look at baseline measures to determine differences in responses to four subjective (affect/cognition/attention) stress tasks (primary endpoints) and biological (secondary endpoints) measures in a high stress group and a low stress group.
If for Step 1 of the study, the investigator's are able to verify the stratification of the participants into high and low stress groups based on questionnaire data and show differences between participants with high and low perceived stress in psychological characteristics, lab stress tasks and potentially in biological responses, this will help to determine the optimal cut off values, and the optimal stress tasks to be conducted in the planned probiotic intervention study of Step 2.
Looking for future studies?
Notify Me18 year–45 year
Female
Interventional
Not applicable
Los Angeles, California, 90095, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Diet:
Other Exclusions:
Medications not Authorized:
Cognitive and stress study with no product intervention and noninvasive. The high stress/anxiety group will be compared to the low stress/anxiety group in terms of changes from baseline to after the cognitive and stress tests (i.e., 4 laboratory tasks) and metabolite measures.
Other names: ANS testing, metabolites, cognitive tasks, stress tasks
Time frame: Pre and Post laboratory testing during the in-clinic visit lasting 2-4 hours.
Between group differences in pre-and post- of the "overall" negative and positive affect subscale scores from the Positive Affect and Negative Affect Scale (PANAS) administered at baseline immediately before and after the 4 brief and well validated laboratory stress tasks. PANAS scores can range from 10-50 for both the positive and negative affect, with the lower scores representing lower levels of positive/negative affect, and higher scores representing higher levels of positive/negative affect.
Time frame: Throughout the Color Stroop laboratory test at the in-clinic visit lasting approximately 30 minutes.
Between and within group differences on the time it takes to complete the Color Stroop attention/executive function lab stress task.
Time frame: Throughout the IAPS laboratory test during the in-clinic visit lasting approximately 30 minutes.
Between and within group differences in valence and emotional arousal ratings during the IAPS task.
Time frame: Pre and Post the arithmetic stress task during the in-clinic visit lasting approximately 30 minutes.
Between and within group differences on the negative affect subscale from the Brief Positive Affect and Negative Affect Scale (PANAS) before and after the arithmetic task. PANAS scores can range from 10-50 for both the positive and negative affect, with the lower scores representing lower levels of positive/negative affect, and higher scores representing higher levels of positive/negative affect.
Time frame: Throughout each laboratory test during the in-clinic visit lasting 2-4 hours.
Between and within group differences in overall average change in heart rate variability pre and post each laboratory stress task.
Time frame: Throughout the Trails A & B laboratory tests at the in-clinic visit lasting approximately 30 minutes.
Between and within group differences on the time it takes to complete the Trails A and B attention/executive function lab stress task.
Time frame: Throughout each laboratory test during the in-clinic visit lasting 2-4 hours.
Between and within group differences in overall average change in both diastolic and systolic blood pressure pre and post each laboratory stress task.
Time frame: Throughout each laboratory test during the in-clinic visit lasting 2-4 hours.
Between and within group differences in overall average change in skin conductance pre and post each laboratory stress task.
Time frame: Pre and Post laboratory testing during the in-clinic visit lasting 2-4 hours.
Between and within group differences in pre- and post- laboratory stress tasks in targeted stress-related metabolite concentrations assessed with the Ixcela Panel and analyzed using a Welch's two-sample t-test to identify overall metabolite changes. Extensive literature details the role of metabolites in modulation of the brain, and widespread effects on excitatory neurotransmission and neuroinflammation. (Metabolites Targeted will include the following pathways: Tryptophan, Purine, Serotonin, Kynurenine, Hypoxanthine, Xanthosine, Xanthine, Guanosine, Guanine, Uric Acid, Methionine, 4-Hydroxy 3-Methoxy Phenylacetic Acid, DL 4-Hydroxy, 3-Methoxy Mandelic Acid, Methoxy Hydroxyphenyl, Glycol, 4HPLA, 2HPAC, 4HPAC).
University of California, Los Angeles
Other
Pilot Study Aimed to Determine the Optimal Design for the UCLA/Danone Probiotic Intervention Study Related to Stress
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07731464
Anxiety, Anxiety Disorders
Islamabad, Federal, Pakistan
View Trial DetailsNCT07255365
Anxiety, Anxiety Disorders
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT05451589
Anxiety, Anxiety Disorders
Ann Arbor, Michigan, United States
View Trial DetailsNCT07566026
Anxiety, Anxiety Disorders
Istanbul, Turkey (Türkiye)
View Trial Details